Lara M L, Layrisse Z, Scorza J V, Garcia E, Stoikow Z, Granados J, Bias W
Centro de Medicina Experimental, Instituto Venezolano de Investigaciones, Caracas.
Hum Immunol. 1991 Feb;30(2):129-35. doi: 10.1016/0198-8859(91)90081-j.
Twenty-four families with one or multiple cases of localized cutaneous leishmaniasis (LCL) from an endemic region with the highest incidence of LCL in Venezuela were typed from HLA-ABC, DR, DQ antigens and complement factors. The parental HLA haplotypes segregated at random among healthy and affected siblings but in backcross families significantly higher frequencies of HLA-A28 (p = 0.0018), -Bw22 (p = 0.0122), or -DQw8 (p = 0.0364) were present in affected compared to healthy siblings. HLA-B15 showed a higher frequency (p = 0.0062) among the latter group. Haplotypes Bw22CF31 (p = 0.0076) and Bw22DRw11DQw7 (p = 0.0163) were also significantly more frequent in affected compared to healthy siblings and A2Cw- (p = 0.0445) among the latter. No HLA genetic linkage with a putative LCL susceptibility gene(s) could be demonstrated in this study. A case/control comparison of 26 unrelated LCL patients (one proband from each family) and healthy individuals of the same ethnic origin confirmed the association of HLA-Bw22 (pc = 0.048) and -DQw3 (pc = 0.036) with LCL. The relative risk reached 12.5 for Bw22 and 4.25 for DQw3 with ethiologic factors of 0.17 and 0.64, respectively. HLA-DQw3 apparently makes the major contribution as a genetic risk factor for LCL at the population level.
来自委内瑞拉局部皮肤利什曼病(LCL)发病率最高的流行地区的24个有一例或多例LCL病例的家庭,对其HLA - ABC、DR、DQ抗原和补体因子进行了分型。父母的HLA单倍型在健康和患病的兄弟姐妹中随机分离,但在回交家庭中,与健康兄弟姐妹相比,患病兄弟姐妹中HLA - A28(p = 0.0018)、- Bw22(p = 0.0122)或 - DQw8(p = 0.0364)的频率显著更高。HLA - B15在后一组中的频率更高(p = 0.0062)。与健康兄弟姐妹相比,单倍型Bw22CF31(p = 0.0076)和Bw22DRw11DQw7(p = 0.0163)在患病兄弟姐妹中也显著更常见,而A2Cw - (p = 0.0445)在后一组中更常见。在本研究中未证明HLA与假定的LCL易感基因存在遗传连锁。对26名不相关的LCL患者(每个家庭一名先证者)和相同种族的健康个体进行病例/对照比较,证实了HLA - Bw22(pc = 0.048)和 - DQw3(pc = 0.036)与LCL的关联。Bw22的相对风险达到12.5,DQw3的相对风险达到4.25,病因学因素分别为0.17和0.64。在人群水平上,HLA - DQw3显然是LCL的主要遗传风险因素。